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Summary Tumour cell adhesion, detachment and aggregation seem to play an important part in tumour
invasion and metastasis, and numerous cell adhesion molecules are expressed by tumour cells. Several families
of cell-cell adhesion molecules have been described, of which two groups are particularly well characterised,
the cadherin family and the Ig superfamily member, neural cell adhesion molecule (NCAM). We investigated
expression of these two adhesion molecule families in small cell lung cancer (SCLC) cell lines and xenografts
by immunoblotting. Nineteen tumours established from 15 patients with SCLC were examined. All tumours
but one expressed both cadherin and NCAM. The tumours expressed one, two or rarely three cadherin bands,
and different combinations of two major isoforms of NCAM with Mr'S of approximately 190,000 and 135,000.
Polysialylation of NCAM, a feature characteristic of NCAM during embryonic development, which may play
a role in connection with tumour invasion and metastasis, was found in 14/18 NCAM expressing SCLC
tumours. Individual tumours grown as cell lines and as nude mouse xenografts showed no qualitative
differences in cadherin or NCAM expression.
Small cell lung cancer (SCLC) is a common human malig-
nancy with an aggressive behaviour and a high tendency to
metastasize. Tumour cell adhesion, detachment and aggrega-
tion seem to play an important part in tumour invasion and
metastasis, and cell adhesion molecules are frequently ex-
pressed by tumour cells (Nicolson, 1988; Thiery et al., 1988;
Linnemann et al., 1989; Shimoyama et al., 1989). Cell-cell
adhesion molecules may be classified into several groups
(Takeichi, 1991; Bock, 1991; Linnemann & Bock, 1989) of
which the cadherin family constitutes one important group,
and the Ig superfamily member, neural cell adhesion mole-
cule (NCAM) another. Both these families of adhesion mole-
cules have been attributed a role in embryonic development
and both are expressed in certain forms of cancer as well as
in several normal adult tissues (Thiery et al., 1988).
Cadherins are a family of cell adhesion molecules of which
several subclasses are well characterised. Four major sub-
classes are termed N-cadherin (Mr 127-135.000), E-cadherin
(Mr 124.000) (also designated uvomorulin), P-cadherin (Mr
118.000), and L-CAM (Mr 124.000) (Takeichi, 1991). The
cadherin family members are differentially expressed during
morphogenesis, and may play a role in tumour invasion and
metastasis, but the functional differences between the
members have not been clarified.
At present, only little is known about cadherin expression
in SCLC (Shimoyama et al., 1989).
NCAM is widely expressed during embryonic development
as well as in adult neural and several other tissues and in
certain tumours (Schol et al., 1988; Thiery et al., 1988). It
exists in several different isoforms varying in their Mr, mainly
due to differences in length of the C-terminal end of the
molecule (for reviews, see Nybroe, Linnemann & Bock, 1988;
Linnemann & Bock, 1989). All isoforms are encoded by the
same gene due to alternative mRNA splicing (Owens, Edel-
man & Cunningham, 1987; Santoni et al., 1989). Three iso-
forms with Mr's of approximately 190, 135 and 115 kD are
most commonly expressed, and are therefore termed major
isoforms. The specific functional role played by each of these
isoforms is not known.
A characteristic of NCAM is that it may contain various
amounts of a2,8-linked polysialic acid (PSA) side chains
(Finne, 1982), which may profoundly alter its homophilic
binding abilities (Hoffman & Edelman, 1983; Rutishauser et
al., 1988), and thereby possibly the invasive and metastatic
capacity of the cells expressing NCAM.
NCAM expression has been reported to be present in
almost all cases of SCLC (Souhami et al., 1991; Kibbelaar et
al., 1989; Aletsee-Ufrecht et al., 1990). Most previous studies
of NCAM expression in SCLC have utilised immunohisto-
chemical investigation. This method gives information about
the subcellular localisation of NCAM, but it does not enable
distinction between the different isoforms, neither does it
provide detailed information about NCAM polysialylation,
although demonstration of polysialylation is possible with
appropriate antibodies (Kibbelaar et al., 1989; Souhami et
al., 1991).
In the present study cell lines and nude mouse xenografts
of SCLC tumours established from 15 patients were investi-
gated for expression of cadherin and NCAM products by
Western blotting. This method enables a semiquantitative
determination of the level of adhesion molecule expression. It
also allows determination of the Mr of the expressed cadherin
and NCAM molecules, and an estimation of the degree of
NCAM polysialylation. The use of tumour material grown in
two different model systems provides information about
whether expression of adhesion molecules may be influenced
by the growth conditions of the tumour cells or whether it is
an inherent characteristic of the cells.
The study is the first report of cadherin expression in a
large panel of SCLC tumours based on immunoblotting, and
it provides new data on the expression of NCAM isoforms in
this disease. Furthermore, comparison of expression levels of
adhesion molecules in cell lines and xenografts in nude mice
has not been published previously.
Materials and methods
Cell lines and tumour xenografts
Nineteen tumours established from 15 patients were investi-
gated. Four tumours were grown only as xenografts, one
tumour only as cell line, while the remaining were investi-
gated both as cell lines and as xenografts.
Cell lines were grown at 37°C in a humidified atmosphere
containing 5% CO2. Media contained 10% foetal calf serum.
Tumours designated CPH were established in Copenhagen,
Denmark (Engelholm et al., 1986), DMS tumours at
Correspondence: K. Rygaard, University Institute of Pathological
Anatomy, Frederik V's Vej 11, DK-2100 Copenhagen 0, Denmark.
Received 8 October 1991; and in revised form 12 December 1991.
Br. J. Cancer (1992), 65, 573-577 '." Macmillan Press Ltd., 1992574 K. RYGAARD et al.
Dartmouth Medical School, NH, USA (Pettengill et al.,
1980), the NCI tumour at the National Cancer Institute,
MD, USA (Carney et al., 1985), and GLC tumours at
University Hospital of Groningen, The Netherlands (de Leij
et al., 1985; Berendsen et al., 1988). CPH-54A and CPH-54B
are in vitro established subclones of the same original tumour
(Engelholm et al., 1985). GLC-14, GLC-16, and GLC-19
were established from the same patient during longitudinal
follow-up (Berendsen et al., 1988). Cell lines were regularly
tested and found free of Mycoplasma infection.
Cells for investigation were harvested in mid- to late
exponential growth phase. Harvesting was done by scraping
with a rubber policeman for cells growing attached to the
bottom of culture flasks, and by aspiration for cells growing
as floating aggregates. The cells were washed in sterile buffer
(150 mm NaCl; 10 mm EDTA; 10mM Tris; pH 8.0), spun
down, immediately frozen in liquid nitrogen, and stored at
-80°C until further processing.
Xenografts were established in the flanks of nude mice by
s.c. inoculation of 106_ 101 cells from cell lines, or directly
from patients by inoculation of 2 mm-diameter tumour
blocks (Spang-Thomsen, Nielsen & Visfeldt, 1980). Serial
transplantation was performed by s.c. inoculation of 2 mm-
diameter tumour blocks under general anesthesia. The mice
were of NMRI or BALB/c origin and in specific pathogen-
free status; they were kept in laminar air-flow clean benches.
Sterile food and water were given ad libitum.
Tumour samples for investigation were cut free of visible
necrotic tissue, immediately frozen in liquid nitrogen, and
stored at -80°C.
Protein extraction, electrophoresis and immunoblotting
Cell and tissue samples for proteins extraction were homo-
genised in lysis buffer (25 mM Tris (pH 7.5); 50 mM NaCl;
0.5% (w/v) sodium-deoxycholate; 1% (v/v) Nonidet P-40;
0.1% (w/v) sodium dodecyl sulfate (SDS); 1 mM phenyl-
methylsulfonyl fluoride (PMSF); 500 KIE/ml aprotinin
(Trasylol, Bayer)), homogenised by ultrasonication, and
centrifuged for 15 min at 12,000g. The supernatant was
transferred to a new tube and the protein concentration
determined by the Bradford method (Bradford, 1976) using a
commercial kit (Bio-Rad, CA). Sample buffer was added to
the supernatant to give a final protein concentration of
2 Ag I1-l. The samples were boiled for 5 min and size-
fractionated by electrophoresis through SDS containing 7.5%
polyacrylamide gels (SDS-PAGE, Laemmli, 1970) on a
'Phast' SDS-PAGE electrophoresis unit (Pharmacia, Sweden).
In cadherin experiments 2fig total protein samples were elec-
trophoresed per lane (eight lanes per gel), in NCAM experi-
ments 8 jLg (six lanes per gel). Mr was determined with
reference to molecular weight markers in the range from
44,000 to 200,000 (Bio-Rad, CA) and to NCAM bands in
human brain and cadherin bands in new-born rat brain.
The electrophoretically separated proteins were transferred
to polyvinylidene difluoride (PVDF) membranes (Immobilon
P, 0.22 jim, Millipore, France) by semi-dry electroblotting
(Kyhse-Andersen, 1984) according to the manufacturers in-
structions (JKA, Copenhagen, Denmark). Membranes were
blocked for 4 min in washing buffer (50 mM Tris, 350 mM
NaCl, 0.1 mM PMSF, 0.05% (v/v) Tween-20 and 0.1% (w/v)
BSA, pH 10.2) containing 2% Tween-20, washed for 3 x 10
min in washing buffer and subsequently incubated for 2 h
with the relevant antibody.
The polyclonal cadherin antibody was raised in rabbits
against a fusion protein produced from a combination of the
,-galactosidase gene and a cDNA encoding amino acids
717-912 of chicken N-cadherin. The antibody reacts with
N-cadherin in rat and human brain and with rat muscle, rat
heart and rat liver (A.-M. Dalseg, K. Edvardsen & E. Bock,
unpublished data). Comparison of the antibody with the
N-cadherin antibody raised by Lagunowich et al. (1990),
kindly supplied by the authors, has shown identical reactivity
with all tested rat tissues. However, we cannot exclude the
possibility that our N-cadherin antibody may also react with
other cadherin family members, which are known to have
pronounced homology in their C-terminal part. The reacti-
vity of the cadherin antibody could be completely eliminated
by pre-incubation with the fusion protein used for immunisa-
tion (data not shown).
For NCAM immunoblotting, a polyclonal rabbit antibody
was used, which recognises all three major NCAM isoforms
irrespective of the presence or absence of polysialylation
(Moolenaar et al., 1990); the specificity of this antibody has
been described previously (Rasmussen et al., 1983). Follow-
ing incubation with primary antibody, the membranes were
washed and incubated for 1 h with alkaline phosphatase-
conjuated swine anti-rabbit antibody (Dakopatts, Glostrup,
Denmark) diluted 1:1000. After washing, bound antibody
was visualised by a chromogenic reaction catalysed by the
conjugated alkaline phosphatase using nitroblue tetrazolium
and 5-bromo-4-chloro-3-indolyl phosphate as the chromo-
genic substrate.
Results
The results are summarised in Table I. Expression of both
cadherin and NCAM was found in all investigated tumours
except DMS-114 (Figures 1 and 2). The tumours expressed
one or two cadherin bands (e.g. CPH-54B and DMS-92) of
slightly different size, the Mr of both being around
125-130.000. The larger band, which was expressed in all
cadherin-positive tumours is most likely N-cadherin, since
this band co-migrated closely with the N-cadherin band seen
in rat brain. The smaller cadherin band recognised by the
antibody may represent any of the other cadherin family
members. NCAM was expressed as isoforms with Mr's of
approximately 190.000 and 135.000. Some tumours expressed
mainly the 135.000 isoforms (e.g. CPH-186) whereas other
tumours expressed both isoforms (e.g. DMS-406). In most of
the tumours a cloudy area was visible on the Western blots
above the bands caused by one of the major NCAM iso-
forms (e.g. DMS-92). This smear most likely represented
polysialylation of NCAM, since varying degrees of poly-
sialylation increases the molecular weight of NCAM to
different extents, thus causing a smear on Western blots.
Extracts of human and rat brain, which were included on
all blots as positive controls for NCAM and cadherin,
respectively, were always positive.
There was a tendency towards higher levels of expression
of both cadherin and NCAM in tumours propagated in vitro
than in the same tumour grown in nude mice. However,
there was no qualitative difference in the expression, since all
tumours expressed the same cadherin and NCAM bands in
the two model systems (Table I).
Substitution of the primary antibodies with non-immune
rabbit sera gave no bands which could be confused with the
bands caused by adhesion molecules under study (data not
shown). To exclude presence of soluble adhesion molecules in
calf serum which was part of the cell growth medium, serum
samples were electrophoresed and immunoblotted as describ-
ed above. Neither cadherin, nor NCAM was detected in the
calf serum.
Discussion
Eighteen of the 19 investigated SCLC tumours expressed
both N-cadherin and one or more NCAM isoforms. This
high frequency of expression of cell-cell adhesion molecules
in SCLC indicates that adhesion molecules have important
functions in this disease.
We found expression of N-cadherin in 18/19 SCLC
tumours and thus demonstrate that cadherin expression in
SCLC is very common. Using immunohistochemistry, E-
cadherin and P-cadherin expression has previously been dem-
onstrated in 44 lung carcinomas (Shimoyama et al., 1989), of
which 2/2 SCLC cell lines were found to be positive.
In ten of the 18 cadherin expressing tumours the WesternCADHERIN AND NCAM EXPRESSION IN SCLC 575
0 0 0 -o 0 o
* C 0 C G) C o 0 0 0 c
c 0 0 * 0 C c 0 C 0D 0 C 0 C 0 C
CDCD r~~~~~~. CD~W = X m C') to CD C= x = X 0 0)
CD ~~~~~~ N1. NM
LO LCD CD co CY) C CD LO 9-1 ~ ~ ~ ~~~~~I I-~Y W y
=z ~~~~~~~~~~~~~U) (flUCA C) U) (f 6 6 6 6I 04 0- 0 0 -j - j -UJ - oL oL
EL u a a a o 0 Z) Z 1)
C D CDI
D CD
Figure 1 Representative Western blots demonstrating cadherin expression in SCLC cell lines and xenografts. The position of the
cadherin band(s) is indicated by arrows.
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Figure 2 Representative Western blots demonstrating NCAM expression in SCLC cell lines and xenografts. The position of the
190.000 and 135.000 Mr isoforms is indicated by arrows. Polysialylation is seen in some of the tumours (e.g. DMS-92), see Table I
and text.
Table I Expression of cadherin and of NCAM proteins in SCLC cell lines and xeno-
grafts
Cadherin NCAM
Tumour Line Xeno Line Xeno
CPH-54A + + + [S] + [S] + [A,B,P] (+) [A,B,P]
CPH-54B + + + [S] + [S] + + [A,B,P] + + [A,B,P]
CPH-136A NA + + [D] NA + + + [B,P]
CPH-136B NA + + [D] NA + + + [B,P]
CPH-167 - NA + + [DI NA + + [B,P]
CPH-186 NA + + [D] NA + + [B,P]
DMS-53 + + + [S] + + [S] + + + [A,B,P] + [A,B,P]
DMS-79 + [S] (+) [S] + + + [A,B,P] + [A,B,P]
DMS-92 + + + [D] + + [D] + + + [A,B,P] + + [A,B,P]
DMS-114
DMS-153 + + + [D] + + [D] + + + [A,B,P] + + [A,B,P]
DMS-273 (+) [S] + [S] + [A,B] (+)
DMS-406 + + [S] NA + + + [A,B,P] NA [A,B]
DMS-456 + + + [D] + + [D] + + [A,B] + [A,B]
GLC-3 + + + [D] + + [D] + [A,B,P] (+) [A,B,P]
GLC-14 + [D] + [DI + + + [A,B,P] + + [A,B,P]
GLC-16 + + + [D] + + [D] + + + [A,B] + + [A,B]
GLC-19 + + [D] + + [D] + + + [A,B] + + [A,B]
NCI-H69 + [S] + [S] + + + [A,B,P] + + + [A,B,P]
The level ofexpression was rated visually as none: '-', trace: '(+)', weak: '+', moderate:
'+ +' orhigh: '+ + +'. For cadherin the presence ofa single '[S]' ordouble/triple '[D]' band
on Western blots is indicated. Expression of the major NCAM isoforms NCAM-190 and
NCAM-135 is indicated as '[A]' and '[B]', respectively. Polysialylation ofNCAM is indicated
by '[P]'. NA, not available.
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blots showed more than one band (Table I, Figure 1).
Cadherin antibodies binding to the C-terminal part of
cadherin, as does the antibody used in this study, has been
reported to recognise both E-, N-, and P-cadherin (Geiger et
al., 1990). N-cadherin is the largest of the known cadherins,
and thus the larger band found in all cadherin expressing
tumours is very likely to be N-cadherin. This assumption is
favoured by the fact that the large band always co-migrated
closely with the N-cadherin band in rat brain tissue. The
smaller band found in ten of the tumours may represent one
of the other described cadherin family members, a break-
down product of N-cadherin, or yet unidentified members of
the cadherin family. With the increasing knowledge about the
complexity of the cadherin family, it is evident that some
caution must be exercised when interpreting results obtained
with antibodies with broad cadherin family reactivity. Four
cadherin subclasses have been well characterised, namely E-,
N-, P-cadherin and L-CAM (Takeichi, 1991) but several
more may exist (Suzuki, Sano & Tanihara, 1991).
NCAM was expressed in 18/19 of the tumours. This is in
agreement with previous reports of very frequent expression
of NCAM in SCLC (Schol et al., 1988; Kibbelaar et al.,
1989; Aletsee-Ufrecht et al., 1990).
While NCAM has for some time been known to be
expressed in SCLC, little was known about which isoforms
of NCAM that were expressed in this disease (Souhami et al.,
1991). This is due to the fact that the majority of previous
studies have employed immunohistochemical methods for
demonstration of NCAM; such methods do not allow dis-
tinction between the various NCAM isoforms. In one study
of NCAM expression in seven SCLC cell lines by immuno-
blotting (Aletsee-Ufrecht et al., 1990), only the NCAM-135
isoform was demonstrated (termed NCAM 140 in their
study). In two other previous studies in which SCLC NCI-
H69 was included (Kibbelaar et al., 1989; Moolenaar et al.,
1990), this tumour was shown to express both NCAM-190
and NCAM-135. The expression of these two major isoforms
in NCI-H69 was confirmed in the present study. We found
coexpression of NCAM-190 and NCAM-135 in more than
half of the examined tumours, demonstrating that, in SCLC,
two NCAM isoforms are commonly co-expressed. Since the
role of the different NCAM isoforms is not settled, the
possible biological implications of the difference in NCAM
isoform expression between various SCLC tumours remains
obscure.
It has recently been demonstrated, that the antigen recog-
nised by SCLC cluster one (Cl 1) antibodies (Souhami et al.,
1991) is identical to NCAM (Patel et al., 1989; Moolenaar et
al., 1990). Most SCLC tumours investigated so far have been
found to express NCAM, while expression is found in only a
few non-SCLC lung tumours (Mooi et al., 1988; Kibbelaar et
al., 1989; Aletsee-Ufrecht et al., 1990).
We detected polysialylation in 14/18 tumours (Table I), but
we cannot rule out the possibility that a lower level of
polysialylation may be present in the tumours scored as
negative. Low levels of polysialylation may be detectable
with antibodies with high affinity for a2,8-linked polysialic
acid side chains. Polysialylation of NCAM profoundly
reduces the homophilic binding properties of cells (Rutis-
hauser et al., 1988) and may facilitate migration of the cells
due to altered cell-cell interactions. Thus, it could be
speculated that the presence of polysialylation of NCAM on
SCLC cells may contribute to the highly metastatic
behaviour of this tumour type.
Qualitatively, the expression pattern of cadherin and
NCAM was independent of whether the individual tumours
were grown in vitro as cell lines or in vivo as nude mouse
xenografts. However, a tendency towards higher expression
in cell lines than in xenografts was noted. The difference may
to some extent be caused by the presence in xenografts of
murine stroma, which causes a dilution of the tumour cells.
Despite the possible slight difference in the level of cadherin
and NCAM expression between cell lines and xenografts, the
demonstration of these adhesion molecules both in cell lines
and in xenografts is evidence that expression is an inherent
characteristics of the SCLC tumour cells, and not a pheno-
typic feature induced by the growth conditions. This notion
is supported by the consistent demonstration of NCAM ex-
pression in SCLC in surgical biopsies (Mooi et al., 1988;
Kibbelaar et al., 1989; Tome et al., 1990), as well as in cell
lines established from patients with this disease (Kibbelaar et
al., 1989; Moolenaar et al., 1990; Aletsee-Ufrecht et al.,
1990).
It has been suggested that NCAM expression may be a
feature specific of SCLC cell lines growing as floating aggre-
gates in in vitro culture whereas cells growing adherent to the
bottom of culture flasks express less or no NCAM (Doyle et
al., 1990). Our data do not support this hypothesis since the
CPH cell lines, the DMS cell lines except DMS-79, and
GLC-3 grew attached to the bottom of culture flasks. Thus,
10/14 cell lines expressed NCAM and grew attached.
At least three different types ofcell-cell adhesion molecules
are expressed on SCLC cells. Apart from cadherin and
NCAM, also PI integrin is expressed in a large proportion of
SCLC cells (Feldman et al., 1991). Cell-cell adhesion mole-
cules are likely to be involved in the process of metastasis
(Nicolson, 1988; Thiery et al., 1988; Takeichi, 1991). How-
ever, it is not clear what influence adhesion molecules on the
surface ofcancer cells have on their ability to metastasise. On
one hand adhesion molecules may retard the escape of
tumour cells from the primary site due to increased adhesion
to other cells and to intercellular matrix proteins, but on the
other hand adhesion molecules may be necessary for the cells
to attach to a secondary, i.e. metastatic, site. However,
decreased metastatic potential of cells expressing NCAM was
reported (Andersson et al., 1991) and also increased invasive
and metastatic potential upon loss of cadherin expression
(Behrens et al., 1989; Hashimoto et al., 1989; Vleminckx et
al., 1991) has been described. Hence, the functional role of
adhesion molecules in invasion and metastasis is complex,
and it may seem surprising that SCLC which is highly metas-
tatic in patients, expresses several types of adhesion mole-
cules.
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